Tuesday, October 22nd, 2024

Early Uptrend Signals Strong Growth Potential for HKBN Ltd

Date: October 22, 2024
Broker: CGS International Securities


Overview of HKBN Ltd (1310)

HKBN Ltd. provides a range of telephone voice and data communication services, including wireless internet services, IDD and IPTV services, local telephony, and other value-added offerings.

Current Stock Status

  • Last Price: HK$3.29
  • Trend: Early uptrend intact
  • Technical Buy Recommendation: The stock shows signs of continued growth, indicating a positive trend.

Key Technical Indicators

  1. Price Action:

    • Reached the first target price (TP) of HK$3.18 as per the recent analysis dated September 16, 2024.
    • Currently displaying strong continuation to the upside.
    • Higher highs and lows are forming, confirming the uptrend.
  2. Chart Patterns:

    • Formation of a larger V-shaped bottom.
    • Breakout of the pennant signal suggests further upside potential.
  3. Technical Analysis:

    • The stock is trading above all Ichimoku indicators.
    • Positive MACD histogram, with the MACD/Signal line rising and staying above the zero line.
    • The 23-period ROC has slightly dipped but remains above the zero line.
    • Directional Movement Index indicates continued bullish strength.
    • Volume expansion shows a healthy trend.

Entry and Exit Points

  • Entry Prices: HK$3.29, HK$2.94, HK$2.60
  • Support Levels:
    • Support 1: HK$5.89
    • Support 2: HK$4.98
  • Resistance Levels:
    • Resistance 1: HK$6.30
    • Resistance 2: HK$8.50
  • Stop Loss: HK$2.25
  • Target Prices:
    • Target 1: HK$3.70
    • Target 2: HK$4.00
    • Target 3: HK$4.60
    • Target 4: HK$6.40

Analyst Notes

Analyst Chua Wei Ren, CMT, suggests adding to the buy position based on the strong continuation of the uptrend. The analysis highlights that the stock is demonstrating key technical strength and remains positioned for potential upward movement.

Hyphens Pharma International: Growth Supported by a Healthy Product Pipeline

Hyphens Pharma International: Growth Supported by a Healthy Product Pipeline Overview: Hyphens Pharma International Ltd. (HYP) is a leading specialty pharmaceutical and consumer healthcare company based in Singapore. The company has developed a strong...

Axis REIT Breaks Out of Downtrend, Eyeing New Highs with Strong Bullish Momentum

Report Date and BrokerDate: October 3, 2024Broker: CGS International Company OverviewAxis Real Estate Investment Trust (Axis REIT) operates as a real estate investment trust that owns and invests in industrial and commercial real estate....

Tencent (700 HK): Leading the Charge in China’s Online Gaming Market Recovery

Report Date: 2 October 2024Broker: MIB Securities (Hong Kong) Ltd Game License Approvals and Market Position On 27 September 2024, China’s National Press and Publication Administration (NPPA) approved 109 domestic online games, marking the...